ReGen Biologics , Inc.

ReGen Biologics is a global orthopedic products company that develops, manufactures and markets innovative tissue growth and repair products. ReGen's patented collagen scaffold technology includes applications in orthopedics, general surgery, spine, cardiovascular and drug delivery. The Company's first approved product using its collagen scaffold technology is the CMIâ„¢, a meniscus application cleared for sale in Europe and marketed through the Company's European subsidiary, ReGen Biologics AG. ReGen has submitted a 510(k) to the FDA in the U.S. for clearance of the CMI. ( www.regenbio.com )